Literature DB >> 18467693

CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.

Takamasa Uekita1, Masamitsu Tanaka, Misato Takigahira, Yuri Miyazawa, Yukihiro Nakanishi, Yae Kanai, Kazuyoshi Yanagihara, Ryuichi Sakai.   

Abstract

CUB-domain-containing protein 1 (CDCP1) is a type-I transmembrane protein that is highly expressed in colon, breast, and lung cancers. We recently revealed that CDCP1 is associated with and phosphorylated by Src family kinases and is involved in the regulation of anchorage independence of certain lung cancer cell lines. In this study, we examined whether CDCP1 is involved in the regulation of tumor progression of scirrhous gastric cancer, which is a diffusely infiltrative carcinoma with high invasion potential. Expression and phosphorylation levels of CDCP1 correlated with the invasive potential of scirrhous gastric cancers. Reduction of CDCP1 expression by siRNA suppressed migration, invasion, and anchorage independence without affecting the proliferation of highly invasive scirrhous gastric cancer cells. However, CDCP1 overexpression promoted gastric cancer cell migration with low potential of invasion. Loss of CDCP1 suppressed invasion and dissemination of cancer cells that were orthotopically implanted in the gastric wall of nude mice. Expression and phosphorylation of CDCP1 were also detected in cancer cells of surgically resected tissues of human scirrhous gastric cancer by immunohistochemical analysis. Our results suggest that CDCP1 promotes invasion and peritoneal dissemination of cancer cells through the regulation of cell migration and anchorage independence. Therefore, it is both a potential prognostic and therapeutic target in certain types of gastrointestinal cancers, and suppression of its phosphorylation might be a useful strategy for modulating cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467693      PMCID: PMC2408431          DOI: 10.2353/ajpath.2008.070981

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

Review 1.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

Review 2.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  CDCP1 is a novel marker for hematopoietic stem cells.

Authors:  Tim Conze; Reiner Lammers; Selim Kuci; Marwa Scherl-Mostageer; Norbert Schweifer; Lothar Kanz; Hans-Jorg Buhring
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

4.  Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer.

Authors:  Jan Mollenhauer; Martin Deichmann; Burkhard Helmke; Hanna Müller; Gaby Kollender; Uffe Holmskov; Toon Ligtenberg; Inge Krebs; Stefan Wiemann; Ursula Bantel-Schaal; Jens Madsen; Floris Bikker; Sabine M Klauck; Herwart F Otto; Gerd Moldenhauer; Annemarie Poustka
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

5.  The CUB domain. A widespread module in developmentally regulated proteins.

Authors:  P Bork; G Beckmann
Journal:  J Mol Biol       Date:  1993-05-20       Impact factor: 5.469

6.  Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice.

Authors:  Kazuyoshi Yanagihara; Hiromi Tanaka; Misato Takigahira; Yoshinori Ino; Yoshiyuki Yamaguchi; Tetsuya Toge; Kokichi Sugano; Setsuo Hirohashi
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

7.  Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia.

Authors:  Tod A Brown; Tai Mei Yang; Tatiana Zaitsevskaia; Yuping Xia; Clarence A Dunn; Randy O Sigle; Beatrice Knudsen; William G Carter
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

8.  Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.

Authors:  M Yashiro; Y S Chung; S Nishimura; T Inoue; M Sowa
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

9.  CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.

Authors:  Hans-Jörg Bühring; Selim Kuçi; Tim Conze; Gisa Rathke; Kerol Bartolović; Frank Grünebach; Marwa Scherl-Mostageer; Tim H Brümmendorf; Norbert Schweifer; Reiner Lammers
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

10.  Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody.

Authors:  S Fujita; H Suzuki; M Kinoshita; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-12
View more
  46 in total

1.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

2.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

3.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.

Authors:  Danislav S Spassov; Frederick L Baehner; Ching Hang Wong; Stephen McDonough; Mark M Moasser
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

5.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

6.  The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Authors:  C H Benes; G Poulogiannis; L C Cantley; S P Soltoff
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

7.  Novel surface targets and serum biomarkers from the ovarian cancer vasculature.

Authors:  Dimitra Sasaroli; Phyllis A Gimotty; Harsh B Pathak; Rachel Hammond; Eleni Kougioumtzidou; Dionyssios Katsaros; Ron Buckanovich; Karthik Devarajan; Raphael Sandaltzopoulos; Andrew K Godwin; Nathalie Scholler; George Coukos
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

8.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

9.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Authors:  Brooke M Emerling; Cyril H Benes; George Poulogiannis; Eric L Bell; Kevin Courtney; Hui Liu; Rayman Choo-Wing; Gary Bellinger; Kazumi S Tsukazawa; Victoria Brown; Sabina Signoretti; Stephen P Soltoff; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-01       Impact factor: 11.205

10.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.